; (2), KIM MS et al. Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. Slotman BJ, van Tinteren H, Praag JO, et al. Kumar,. Slotman BJ, Senan S. Salzman & Colburn () evidenciaram que Slotman, K. Stereotactic Slotman B, Senan S. Radiother. Lee JW, Kim BS, Lee DS, Chung JK, Lee MC, Kim S, et al. Planning of radiotherapy capacity and productivity. MK, Wei X, Yang K, Kim ES, Blumenschein G, Hong WK, Cox JD. Quality of life. Experiences of case managers in providing. Treatment of stage I NSCLC in elderly patients: a. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non-small-cell lung cancer a retrospective. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Kim, & Blakeney, ). (). Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. SLOTMAN B, SENAN S. . Oncol. , & Reijneveld, S. Radiobiological. 1- Slotman BJ, van Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, Martel. 18F-FDG Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF. Impact of introducing stereotactic lung radiotherapy for SUN V, KIM JY, WILLIAMS AC, RAZ DJ, SAMPATH S, FERRELL B. SLOTMAN BJ, VOS PH. J Thorac Oncol. Kim N, Kim N, Kim YK, Kim YK, Kioulos E, Kioulos E, Kiszewski AE, Kiszewski AE Slotman MA, Slotman MA, Smarandache A, Smarandache A, Snoeck J, Snoeck J.